π Sun, Skin & Science: The Bright Side of Exposure
Dr. Baliga's 'Podkasts for Curious Docs'
βοΈ Walking on Sunshine? Rethinking Our Relationship with the Sun! π§΄π§¬ New researchβspotlighted in The Economist (Sep 20, 2025)βchallenges old assumptions: Could moderate sun exposure reduce cardiovascular mortality? β€οΈπ From nitric oxide to vitamin D, this FAQ explores the science, nuance, and shifting global guidelines. Letβs talk melanin, mortality, and medicine! ππ‘ #Sunlight #CardiovascularHealth #TheEconomist #PublicHealth #MedicalEducation
info_outline
π« Cardiogenic Shock Survival: Impellaβs Decade-Long Edge
Dr. Baliga's 'Podkasts for Curious Docs'
π¨ Cardiogenic ShockβA Decade Later The DanGer Shock Trial shows that patients with STEMI and shock treated with the Impella CP microaxial flow pump lived 600 more days over 10 years vs standard care alone. π Mortality: 52.5% vs 68.8% (HR 0.70) π οΈ Despite higher adverse events, the survival benefit endured a full decade. π This changes how we think about long-term outcomes in mechanical support. π Time to revisit your shock protocols? #DanGerShock #Impella #CardiogenicShock #STEMI #LongTermOutcomes #NEJM #MCS #Cardiology #SurvivalBenefit #ImpellaCP
info_outline
π Genes, Gradients, and Game-Changers: FAQs on Hypertrophic Cardiomyopathy
Dr. Baliga's 'Podkasts for Curious Docs'
π§ Hypertrophic Cardiomyopathy β A Masterclass from Eugene Braunwald 𧬠π Just published in NEJM (Aug 2025): a sweeping, state-of-the-art review on HCM β from Teareβs first autopsy to myosin inhibitors, AI diagnostics, and gene therapy. π₯ Clinical insights, historical depth, trial data (EXPLORER-HCM, SEQUOIA-HCM, VALOR-HCM), and future-facing advancesβall distilled into one must-read. π SCD prevention, π« LVOT obstruction, π§ͺ MYBPC3/MYH7 mutations, 𧬠proteomics, and more. π Essential reading for cardiologists, geneticists, and...
info_outline
π¬ Silence APOC3, Slash Triglycerides, A New Era in Triglyceride Control
Dr. Baliga's 'Podkasts for Curious Docs'
π¨ New NEJM Study on Olezarsen π¨ In patients with moderate hypertriglyceridemia and elevated cardiovascular risk, monthly subcutaneous olezarsen reduced triglycerides by over 60% at 6 months! ππ₯ β Significant drops in APOC3, VLDL, remnant & non-HDL cholesterol β No rise in LDL-C β Well-tolerated with mild injection-site reactions π¬ APOC3 inhibition emerges as a game-changer in lipidology. π ESSENCEβTIMI 73b Trial | Funded by Ionis Pharmaceuticals #Cardiology #LipidLowering #PrecisionMedicine #NEJM #Olezarsen #TGlowering #CVRisk #TIMI...
info_outline
Dr RR Baliga's Philosophical Discourses: Dogen (Japan, 1200β1253 CE) β Founder of Soto Zen
Dr. Baliga's 'Podkasts for Curious Docs'
πΈ DΕgen Zenji (1200β1253), founder of the SΕtΕ Zen school in Japan, taught that true practice lies in zazenββjust sittingβ π§ββοΈβwhere enlightenment and practice are inseparable. His ShΕbΕgenzΕ continues to inspire mindfulness & presence today. β³β¨ #Zen #Mindfulness
info_outline
NSTEMI: π Less Ischemia, Less Reintervention
Dr. Baliga's 'Podkasts for Curious Docs'
π¨ New Evidence in NSTEMI Care! π« The SLIM Trial shows that FFR-guided complete revascularization during the index procedure in patients with NSTEMI and multivessel disease significantly reduces death, MI, stroke, and repeat PCI compared to culprit-only PCI. π― Key win? Fewer revascularizations, better outcomes β physiology beats anatomy again. π Published in JAMA, presented at #ESC2025 π Read more: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.16189 #Cardiology #NSTEMI #FFR #InterventionalCardiology #EvidenceBasedMedicine #SLIMTrial
info_outline
Real-World Rx π, Real Results π: GLP-1 Agents Slash HFpEF Risk
Dr. Baliga's 'Podkasts for Curious Docs'
π₯ Practice-Changing Evidence in HFpEF! π₯ In a real-world cohort of 97,000+ patients with obesity & type 2 diabetes, semaglutide and tirzepatide reduced risk of heart failure hospitalization or death by over 40% π βοΈ No meaningful difference between the two agents. π§ Findings reinforce STEP-HFpEF & SUMMIT trials and highlight GLP-1 therapiesβ expanding role in cardiometabolic HFpEF π« #Cardiology #HFpEF #GLP1 #Semaglutide #Tirzepatide #T2DM #RealWorldEvidence #JAMA #HeartFailure
info_outline
The AMALFI AF Screening Trial-π Atrial Fibrillation Unmasked: A Modest Win for Mailed Monitors
Dr. Baliga's 'Podkasts for Curious Docs'
π’ Just read the #AMALFI trial in JAMA π° β a landmark remote RCT of AF screening using 14-day ECG patches mailed to older adults at stroke risk π¦π«. At 2.5 years, the patch group had a modestly higher AF detection rate (6.8% vs 5.4%, p=0.03) and increased anticoagulation use ππ§ . Stroke rates were similar βοΈ. π― Key takeaway: Remote, mail-based AF screening is feasible and nudges diagnosis rates β but will it move the needle on outcomes? #AFib #StrokePrevention #RemoteMonitoring #ECG #Cardiology #RCT #JAMA #DigitalHealth #Geriatrics π§π
info_outline
π AFib Gone, OAC Gone? ALONE-AF Challenges Lifelong Therapy
Dr. Baliga's 'Podkasts for Curious Docs'
π¨ New Trial Alert π¨ Can we safely stop anticoagulation after AF ablation? The ALONE-AF Trial π« suggests yesβin selected patients with no AF recurrence, stopping DOACs reduced major bleeding π without increasing stroke risk π§ . π 0.3% vs 2.2% for the composite outcome (P = .02) π Carefully monitored, low-risk patients may benefit most. π Editorial: Recommends shared decision-making π€ & individualized rhythm monitoring. π A potential shift in post-ablation care. π #AFib #Anticoagulation #EPTrials #CardioTwitter #StrokePrevention #JAMA...
info_outline
π¦ πBugged After the Heartbreak? Does H. pylori Screening After MI Prevent GI Bleeds?
Dr. Baliga's 'Podkasts for Curious Docs'
π¨ New Findings from the HELP-MI Trial! πΈπͺπ§ͺ Can routine Helicobacter pylori screening during acute myocardial infarction (MI) hospitalization prevent upper gastrointestinal bleeding (UGIB)? π Over 18,000 patients across 35 Swedish hospitals π Result: No significant reduction in UGIB overall (RR 0.90; P=0.18) π BUT: Clear benefit in patients with anemia (RR 0.44β0.64) and chronic kidney disease (RR 0.75) π§ Key Takeaway: Routine screening isnβt broadly warrantedβbut targeted testing in high-risk AMI patients may be the smarter path forward. π...
info_outlineThree studies examined the health impacts of aircraft noise exposure.
The Heathrow Study (2023) found that nighttime aircraft noise increased cardiovascular events, particularly between 22:00β23:00 and 04:30β06:00, likely due to sleep disturbance and stress-related mechanisms.
π¨ New studies link aircraft noise to serious health risks! π©οΈπ
π Nighttime noise boosts heart disease risk π«
π Increases cognitive decline & dementia risk π§
π Alters heart structure, raising cardiac event risk π
Time for stronger noise regulations! #Health #NoisePollution
The Swedish Longitudinal Cohort (2024) linked long-term exposure to aircraft and railway noise to faster cognitive decline and a higher risk of cognitive impairment, while road traffic noise showed no significant effect.
The UK Biobank Study (2025) revealed that higher nighttime aircraft noise exposure was associated with adverse cardiac remodeling, leading to an increased risk of major adverse cardiac events, with obesity and hypertension acting as mediators.